Disease Overview:Hepatorenal syndrome(HRS)

Hepatorenal syndrome (HRS) is a life-threatening complication of advanced liver disease—most commonly cirrhosis with ascites—characterized by progressive renal vasoconstriction, reduced glomerular filtration rate, and functional acute kidney injury without intrinsic renal pathology. It is classified into two types: Type 1 HRS, marked by rapid deterioration in renal function (serum creatinine doubling to >2.5 mg/dL within days), and Type 2, associated with refractory ascites and slower, chronic renal impairment. Diagnosis requires strict exclusion of other causes of renal failure—including prerenal azotemia, intrinsic nephropathy, and obstructive uropathy—and adherence to international criteria (e.g., ICA-AASLD guidelines). Prognosis remains poor without intervention, with median survival under two weeks for untreated Type 1 HRS.

China offers distinct advantages in managing HRS: leading hepatology and nephrology centers—such as Beijing Union Medical College Hospital and Shanghai Renji Hospital—employ multidisciplinary teams experienced in complex liver-kidney interactions, utilize advanced hemodynamic monitoring (e.g., transpulmonary thermodilution), and routinely perform terlipressin-based pharmacotherapy alongside albumin infusion and, where indicated, transjugular intrahepatic portosystemic shunt (TIPS) or align with global benchmarks: published cohort studies report 60–75% short-term reversal rates in Type 1 HRS with protocol-driven therapy. Treatment costs in China are typically 40–60% lower than in the US or Western Europe, without compromising evidence-based standards. As a dedicated medical tourism agency, we facilitate seamless access for international patients—vetting accredited hospitals, coordinating specialist consultations, clarifying all-inclusive pricing upfront, and providing end-to-end support from visa assistance to post-treatment follow-up.

Medical Treatment Guide

Treatment Options & Itemized Cost Breakdown: Hepatorenal Syndrome (HRS) — Nephrology Department

I. Non-Surgical / Conservative / Medication-Based Management

*Target Criteria*: Type 1 HRS (acute renal failure in cirrhosis), serum creatinine ≥1.5 mg/dL, no shock, no nephrotoxic drugs, urine sodium <10 mmol/L, absence of parenchymal kidney disease.

  • Terlipressin + Albumin Regimen (First-Line)
- Terlipressin (IV): ¥1,200–¥1,800/day (¥36–¥54 USD; 0.5–2 mg q4–6h)

- Human Albumin (20% IV, 100 g/day × 3 days): ¥420–¥630/day (¥12.6–¥18.9 USD) - Daily monitoring (BUN, Cr, Na⁺, BP, urine output): ¥180/day (¥5.4 USD) - *Total 3-day course*: ¥4,500–¥7,500 (¥135–¥225 USD)

  • Midodrine + Octreotide + Albumin (Alternative)
- Midodrine (oral): ¥120–¥180/day (¥3.6–¥5.4 USD)

- Octreotide (SC/IV): ¥360–¥540/day (¥10.8–¥16.2 USD) - Albumin (same as above): ¥420–¥630/day - *Total 3-day course*: ¥2,700–¥4,200 (¥81–¥126 USD)

  • Diagnostic & Monitoring Labs (Baseline + Daily)
- Serum creatinine, electrolytes, LFTs, CBC, PT/INR: ¥240 (¥7.2 USD)

- Urine sodium/osmolality: ¥160 (¥4.8 USD) - Abdominal ultrasound (liver/kidney morphology): ¥280 (¥8.4 USD)

II. Procedural / Interventional Options

*Eligibility*: Refractory Type 1 HRS despite pharmacotherapy; MELD ≥15; no active sepsis or uncontrolled GI bleeding.

  • Transjugular Intrahepatic Portosystemic Shunt (TIPS)
- Pre-op workup (CT liver + portal vein mapping, right heart catheterization, coagulation panel): ¥2,100 (¥63 USD)

- TIPS procedure (stent placement + hemodynamic assessment): ¥28,000–¥42,000 (¥840–¥1,260 USD) - Post-op ICU monitoring (24–48 h): ¥1,800–¥2,400/day (¥54–¥72 USD)

  • Liver Transplantation (Definitive Therapy)
- Pre-transplant evaluation (cardiac stress test, pulmonary function, infectious serology): ¥6,500 (¥195 USD)

- Transplant surgery + 7-day ICU/stay: ¥320,000–¥480,000 (¥9,600–¥14,400 USD) - *Note: HRS reversal post-transplant occurs in >85% of survivors.*

III. Special/Complex Scenarios

  • HRS with Acute-on-Chronic Liver Failure (ACLF): Requires CRRT support (¥1,200–¥1,800/day; ¥36–¥54 USD) + ICU admission (¥2,400/day; ¥72 USD).
  • Recurrent HRS post-TIPS: Consider salvage transplant or palliative albumin infusions (¥1,260/week; ¥38 USD).

Quick Selection Guide

  • <60 years, MELD ≤20, budget <¥10,000: Start terlipressin + albumin (¥135–¥225 USD); monitor closely.
  • MELD ≥25, refractory to meds, no contraindications: Proceed to TIPS (¥840–¥1,260 USD) — improves 1-year survival by 35%.
  • Age 60–75, comorbid diabetes/CAD, MELD ≥30: Prioritize liver transplant evaluation (¥9,600–¥14,400 USD); avoid TIPS if cardiac reserve poor.
  • >75 years or frailty with ACLF grade 3: Focus on supportive care (albumin + diuretic optimization) — average cost ¥3,600/month (¥108 USD).
⚠️
Disclaimer: The treatment and cost information above is compiled from internet resources and AI assistance for reference only. Actual treatment plans and itemized costs are subject to in-person hospital consultation and physician evaluation.
💡 International Medical Services Guide ✨ International Direct Billing & GOP Supported

Pricing & Service Differences: International / VIP Dept vs. Regular Clinic

International Medical Services (IMS / VIP Departments) at Grade-3A public hospitals and private international clinics operate under self-regulated VIP fee schedules. Fees are higher than standard public clinics (which are subsidized solely for domestic citizens and do not accept overseas insurances). In exchange, international patients receive 6 exclusive medical privileges:

🌐
1-on-1 Multilingual Medical Interpreters
Dedicated language support assisting with consultations, medical history, and diagnostics.
⏱️
Private VIP Rooms & Zero-Wait Priority Imaging
Exclusive comfortable clinic wings with same-day priority access to MRI, PET-CT, and labs.
🛡️
Global Direct Billing & Cashless Inpatient GOP
Direct settlement with Bupa, Cigna, MSH, Allianz; zero cash deposit required under GOP.
🏨
Private Single Suites, Family Rooms & Custom Meals
Spacious single rooms with ensuite bathrooms, family escort beds, and Western/Halal catering.
🛂
Official S2 Medical Visa Invitation Letters
Expedited stamped acceptance letters & cost estimates complying with Embassy visa requirements.
👨‍⚕️
Senior Chief Physicians & Multi-Disciplinary MDT Panels
30+ min in-depth consultations with China’s foremost professors and leading medical teams.

Recommended Hospitals

Explore selected Grade 3A public hospitals in China with rich clinical experience for this condition:

Peking Union Medical College Hospital
✈️ Approx. 14h 8m · Direct Flights

Peking Union Medical College Hospital

★★★★★ 4.9/5.0
Tertiary Hospital 📍 Beijing Intl Clinic

Peking Union Medical College Hospital (PUMCH) is a top-tier 'Grade III-A' hospit...

View Hospital ➔
Beijing United Family Hospital
✈️ Approx. 14h 8m · Direct Flights

Beijing United Family Hospital

★★★★★ 4.9/5.0
Grade-3A Hospital 📍 Beijing Intl Clinic

Beijing United Family Hospital sits in the heart of Chaoyang District — just 20 ...

View Hospital ➔
Beijing Baihui Medical Center
✈️ Approx. 14h 8m · Direct Flights

Beijing Baihui Medical Center

★★★★★ 4.9/5.0
Grade-3A Hospital 📍 Beijing Intl Clinic

Beijing Baihui Medical Center is a public tertiary Class A hospital — the highes...

View Hospital ➔

🌴 Recommended Hepatorenal syndrome Medical Vacation Packages

Curated transparent all-inclusive packages combining Hepatorenal syndrome treatment with China top medical destinations:

Beijing 5-Day Hepatorenal Syndrome Outpatient Care & Forbidden City Package

✈️ Approx. 14h 8m · Direct Flights

Comprehensive outpatient evaluation and management for hepatorenal syndrome by national renal experts, combined with cultural immersion at the Forbidden City and Temple of Heaven.

Duration: 5 Days (4 Days in China) ✈️ Approx. 14h 8m (Direct Flights) Peking University First Hospital Service: Dedicated Nephrologist Consult + VIP Airport Transfer + 4-Star Hotel
From $ 1,280 USD
* Est. all-inclusive (incl. agency service + hospital fees + transfers)

Shanghai 10-Day Hepatorenal Syndrome Inpatient Care & Huangpu River Wellness Package

✈️ Approx. 15h 14m · Direct Flights

Integrated inpatient care including renal replacement therapy, liver support, and multidisciplinary hepatorenal management, paired with riverside wellness and French Concession relaxation.

Duration: 10 Days (9 Days in China) ✈️ Approx. 15h 14m (Direct Flights) Ruijin Hospital, Shanghai Jiao Tong University School of Medicine Service: Fast-Track Admission + 24/7 Nurse Escort + 5-Star Recovery Stay
From $ 3,500 USD
* Est. all-inclusive (incl. agency service + hospital fees + transfers)

Guangzhou 21-Day Hepatorenal Syndrome MDT Care & Canton Pearl River Luxury Package

✈️ Approx. 22h 34m · Connecting Flights

Comprehensive MDT-led hepatorenal syndrome stabilization, TIPS evaluation, dialysis optimization, and long-term renal-liver coordination—delivered via green-channel access with luxury recovery and Lingnan cultural experiences.

Duration: 21 Days (20 Days in China) ✈️ Approx. 22h 34m (Connecting Flights) The First Affiliated Hospital of Sun Yat-sen University Service: Chief Nephrologist Lead + Family Suite + 24/7 Mandarin/English Care + VIP Sightseeing
From $ 8,500 USD
* Est. all-inclusive (incl. agency service + hospital fees + transfers)

Frequently Asked Questions

❓ What diagnostic tests for hepatorenal syndrome are routinely performed at partner hospitals in China’s nephrology departments?
Partner hospitals—including Peking University First Hospital Nephrology Department and Shanghai Renji Hospital Kidney Center—typically run serum creatinine, sodium, BUN, liver function panels, and renal ultrasound. Some also use cystatin C and urinary biomarkers like NGAL to support differential diagnosis. Ascites fluid analysis and Doppler renal artery studies may be added if cirrhosis complications are unclear. These tests align with international guidelines but are interpreted alongside clinical context. Exact test selection depends on the patient’s liver disease stage and local protocol. Our platform helps coordinate pre-arrival lab requisitions where possible, though final testing scope is determined by the attending nephrologist upon evaluation.
❓ Can international patients receive albumin infusions or terlipressin therapy for hepatorenal syndrome in China—and how does that compare cost-wise to treatment abroad?
Yes—terlipressin (where approved) and human albumin infusions are available at major partner hospitals like West China Hospital and Zhongshan Hospital, under nephrology supervision. Terlipressin requires import authorization; albumin is domestically supplied. Estimated out-of-pocket costs: albumin infusions ~$80–$150 per dose; terlipressin course ~$1,200–$2,500 total. That’s roughly 40–60% lower than US/UK estimates for equivalent regimens. Note: dosing and duration depend on response monitoring—not predetermined. We assist with medication access logistics, but final prescription decisions rest with the treating team.
❓ How long should an international patient plan to stay in China for initial hepatorenal syndrome assessment and stabilization?
Most patients schedule 10–14 days for first evaluation, diagnostics, and short-term management—though some require up to 3 weeks if ascites drainage or repeated lab monitoring is needed. This includes time for interpreter coordination, hospital registration, and follow-up with both nephrology and hepatology teams. Travel insurance must cover acute kidney-liver complications. We help arrange accommodation near partner hospitals (e.g., near Guangzhou First People’s Hospital Nephrology Ward), but visa processing and flight timing remain the patient’s responsibility. Exact duration is confirmed only after medical records review and pre-consultation.
❓ Is liver transplantation considered during hepatorenal syndrome management in China—and what are the eligibility considerations for foreign nationals?
Liver transplant evaluation begins only after nephrology stabilization—and only at designated centers like Tianjin First Central Hospital or Nanjing Drum Tower Hospital, which hold national transplant licenses. Foreign nationals face strict criteria: documented Child-Pugh or MELD score, absence of active infection or malignancy, and proof of financial coverage. Transplant wait times vary widely; no guaranteed timeline exists. Our role ends at referral—we don’t manage transplant lists or approvals. Patients must undergo separate, in-person evaluation by the transplant board. Pre-screening via records review is possible, but final eligibility is always hospital-determined.